Facebook’s Promoted Posts Viewed as Creative and 3 Stock Analyses Making Headlines

Syneron Medical Ltd. (NASDAQ:ELOS): After the firm spoke with management, Cantor believes that Syneron Medical continues to be underappreciated and undervalued. The talks with management left the firm with a positive view regarding the company’s Q3 and 2013. The firm keeps a Buy rating and a $16 price target on the stock.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Facebook, Inc. (NASDAQ:FB): According to Cantor, Facebook’s new product in test launch, titled as Promoted Posts, is a creative manner in which it is able to directly monetize its user base. Promoted Posts prioritize status updates in friends’ News Feeds, wihc raises the probability that the post will be seen. Cantor believes that Facebook shares are attractive, and it keeps its Buy rating on the stock.

Hewlett-Packard Company (NYSE:HPQ) price target was reduced to $15 from $20.50 by CLSA.

Peregrine Semiconductor CorpĀ (NASDAQ:PSMI) recent weakness has been blamed by Oppenheimer on unrealistic content expectations for the iPhone 5. The firm estimates that Peregrine’s iPhone 5 switch content more than doubled from the 4S to 70c per unit from 30c. Oppenheimer believes that the sell-off in Peregrine is a buying opportunity, and it maintains its Outperform rating and a $20 price target on the stock.

Don’t Miss: Facebook Finds a New Way to Boost Revenue.